Laser Therapy for the Treatment of Morphea: A Systematic Review of Literature
Morphea, also known as localized scleroderma (LoS), comprises a set of autoimmune sclerotic skin diseases. It is characterized by inflammation and limited thickening and induration of the skin; however, in some cases, deeper tissues might also be involved. Although morphea is not considered a life-t...
Main Authors: | Paulina Szczepanik-Kułak, Małgorzata Michalska-Jakubus, Dorota Krasowska |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Journal of Clinical Medicine |
Subjects: | |
Online Access: | https://www.mdpi.com/2077-0383/10/15/3409 |
Similar Items
-
Serum Levels of Selected IL-1 Family Cytokines in Patients with Morphea
by: Paulina Szczepanik-Kułak, et al.
Published: (2022-10-01) -
Usefulness of Dermoscopy in Localized Scleroderma (LoS, Morphea) Diagnosis and Assessment-Monocentric Cross-Sectional Study
by: Paulina Szczepanik-Kułak, et al.
Published: (2022-01-01) -
Histopathologic spectrum of morphea: a single-center retrospective study
by: Özben Yalçın, et al.
Published: (2024-02-01) -
Apremilast as a treatment for morphea: A case series
by: Merav Koschitzky, BA, et al.
Published: (2022-01-01) -
Effectiveness of PUVA vs. UVA1 phototherapy in the treatment of morphea patients
by: Anna Malewska-Woźniak, et al.
Published: (2021-08-01)